Gene editing has delivered remarkable results against sickle cell disease. Now researchers are working to make these personalized treatments faster, cheaper, and available to far more patients.

The approval in December 2023 of Casgevy and Lyfgenia marked a major milestone in the treatment of sickle cell disease (SCD). This genetic disease, caused by a recessive point mutation in the gene for ...

An exploration of large patient biobanks linked to clinical information has revealed new health conditions associated with sickle cell trait, the status of carrying just one beta globin gene with the ...

A large survey of schoolchildren in Cameroon shows that sickle cell trait does not prevent asymptomatic malaria infections ...

Malaria is one of the deadliest infectious diseases on the planet, afflicting people throughout recorded history. In places ...

Stiff cells organize within the flow, creating low (left) concentration regions and high (right) concentration regions, which drastically increases flow resistance. MINNEAPOLIS / ST. PAUL (02/10/2026) ...

Scientists at St. Jude Children’s Research Hospital found that prematurely old blood stem cells from sickle cell disease may be treatable with anti-aging drugs, and highlight a needed improvement to ...

Learn what sickle cell disease is, who it affects most, today’s treatment options, and how cost and inequities limit access. Sickle cell disease (SCD) is a complex inherited blood disorder that ...